Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Nuvalent Inc | 465,710 | 371,441 | -94,269 | $35.33M | $38.00M | 8.56% | +$2.67M |
| Merus N V | 623,628 | 635,439 | +11,811 | $36.90M | $31.75M | 7.15% | -$5.15M |
| Insmed Incorporated(INSM) | 140,000 | 347,695 | +207,695 | $9.38M | $25.38M | 5.72% | +$16.00M |
| Avidity Biosciences Inc | 517,734 | 475,555 | -42,179 | $21.15M | $21.84M | 4.92% | +$692.8K |
| Erasca, Inc.(ERAS) | 7,816,926 | 6,946,488 | -870,438 | $18.45M | $18.96M | 4.27% | +$516.0K |
| Akero Therapeutics Inc | 625,087 | 639,840 | +14,753 | $14.66M | $18.36M | 4.14% | +$3.69M |
| Veracyte, Inc.(VCYT) | 282,248 | 470,565 | +188,317 | $6.12M | $16.02M | 3.61% | +$9.90M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 184,662 | 255,578 | +70,916 | $7.58M | $13.39M | 3.02% | +$5.81M |
| Cogent Biosciences, Inc.(COGT) | 1,206,214 | 1,221,362 | +15,148 | $10.17M | $13.19M | 2.97% | +$3.02M |
| Intra-Cellular Therapies Inc | 192,345 | 167,110 | -25,235 | $13.17M | $12.23M | 2.76% | -$946.3K |
| Centessa Pharmaceuticals PlcADS | 0 | 744,592 | +744,592 | $0 | $11.91M | 2.68% | +$11.91M |
| UroGen Pharma Ltd.(URGN) | 1,102,000 | 901,129 | -200,871 | $18.49M | $11.44M | 2.58% | -$7.05M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 1,075,812 | 1,099,490 | +23,678 | $7.61M | $11.27M | 2.54% | +$3.66M |
| Poseida Therapeutics Inc | 3,607,999 | 3,687,548 | +79,549 | $10.54M | $10.55M | 2.38% | +$11.0K |
| Verona Pharma PlcADS | 304,633 | 348,866 | +44,233 | $4.40M | $10.04M | 2.26% | +$5.63M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 36,000 | 35,774 | -226 | $8.75M | $9.84M | 2.22% | +$1.09M |
| Geron Corporation(GERN) | 999,270 | 1,801,561 | +802,291 | $4.24M | $8.18M | 1.84% | +$3.94M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 370,000 | 378,746 | +8,746 | $7.60M | $7.29M | 1.64% | -$305.2K |
| Vaxcyte, Inc.(PCVX) | 2,500 | 60,500 | +58,000 | $188.8K | $6.91M | 1.56% | +$6.72M |
| Kalvista Pharmaceuticals Inc | 560,883 | 574,558 | +13,675 | $6.61M | $6.65M | 1.50% | +$46.2K |
| Protagonist Therapeutics Inc | 0 | 146,657 | +146,657 | $0 | $6.60M | 1.49% | +$6.60M |
| C4 Therapeutics, Inc.(CCCC) | 1,442,841 | 1,147,891 | -294,950 | $6.67M | $6.54M | 1.47% | -$122.9K |
| Sarepta Therapeutics, Inc.(SRPT) | 42,000 | 51,245 | +9,245 | $6.64M | $6.40M | 1.44% | -$236.0K |
| Biodesix, Inc.(BDSX) | 1,808,959 | 3,561,094 | +1,752,135 | $2.77M | $6.34M | 1.43% | +$3.57M |
| Elutia Inc.CL A(ELUT) | 1,603,580 | 1,645,808 | +42,228 | $7.95M | $6.27M | 1.41% | -$1.68M |
| ADC Therapeutics SASHS(ADCT) | 1,768,770 | 1,795,080 | +26,310 | $5.59M | $5.65M | 1.27% | +$65.2K |
| Gossamer Bio, Inc.(GOSS) | 5,500,000 | 5,645,352 | +145,352 | $4.95M | $5.57M | 1.25% | +$613.6K |
| Olema Pharmaceuticals, Inc.(OLMA) | 546,863 | 455,082 | -91,781 | $5.92M | $5.43M | 1.22% | -$483.4K |
| Helix Acquisition Corp IiCL A | 500,000 | 513,369 | +13,369 | $5.11M | $5.36M | 1.21% | +$254.7K |
| ABIVAX Société AnonymeADS(ABVX) | 455,800 | 461,660 | +5,860 | $6.03M | $5.32M | 1.20% | -$707.4K |
| Wave Life Sciences, Inc.SHS(WVE) | 495,471 | 627,552 | +132,081 | $2.47M | $5.15M | 1.16% | +$2.67M |
| Disc Medicine, Inc.(IRON) | 101,187 | 103,862 | +2,675 | $4.56M | $5.10M | 1.15% | +$543.3K |
| Biohaven Ltd.(BHVN) | 100,000 | 99,566 | -434 | $3.47M | $4.98M | 1.12% | +$1.50M |
| Celldex Therapeutics, Inc.(CLDX) | 374,910 | 145,000 | -229,910 | $13.88M | $4.93M | 1.11% | -$8.95M |
| Longboard Pharmaceuticals In | 122,849 | 124,353 | +1,504 | $3.32M | $4.14M | 0.93% | +$824.1K |
| Biogen Inc.(BIIB) | 19,365 | 19,940 | +575 | $4.49M | $3.87M | 0.87% | -$624.0K |
| Praxis Precision Medicines, Inc.(PRAX) | 67,296 | 67,045 | -251 | $2.78M | $3.86M | 0.87% | +$1.07M |
| Modular Med Inc | 900,000 | 1,440,000 | +540,000 | $1.42M | $3.24M | 0.73% | +$1.82M |
| Solid Biosciences Inc | 472,995 | 457,739 | -15,256 | $2.68M | $3.19M | 0.72% | +$508.6K |
| BioNTech SEADS(BNTX) | 0 | 26,083 | +26,083 | $0 | $3.10M | 0.70% | +$3.10M |
| Structure Therapeutics IncADS | 70,516 | 70,516 | 0 | $2.77M | $3.09M | 0.70% | +$325.8K |
| Mersana Therapeutics Inc | 2,500,585 | 1,585,786 | -914,799 | $5.03M | $3.00M | 0.68% | -$2.03M |
| Relay Therapeutics, Inc.(RLAY) | 0 | 419,242 | +419,242 | $0 | $2.97M | 0.67% | +$2.97M |
| TELA Bio, Inc.(TELA) | 1,000,000 | 1,124,928 | +124,928 | $4.70M | $2.85M | 0.64% | -$1.85M |
| Compugen Ltd.(CGEN) | 1,501,113 | 1,501,113 | 0 | $2.52M | $2.72M | 0.61% | +$195.1K |
| Cerus Corporation(CERS) | 1,465,744 | 1,495,329 | +29,585 | $2.58M | $2.60M | 0.59% | +$22.2K |
| Zevra Therapeutics, Inc.(ZVRA) | 0 | 350,000 | +350,000 | $0 | $2.43M | 0.55% | +$2.43M |
| Perspective Therapeutics, Inc.(CATX) | 260,009 | 167,986 | -92,023 | $2.59M | $2.24M | 0.51% | -$349.7K |
| BioAge Labs, Inc.(BIOA) | 0 | 100,000 | +100,000 | $0 | $2.08M | 0.47% | +$2.08M |
| Unicycive Therapeutics Inc | 0 | 4,000,000 | +4,000,000 | $0 | $1.63M | 0.37% | +$1.63M |
| Trevi Therapeutics, Inc.(TRVI) | 844,235 | 482,575 | -361,660 | $2.52M | $1.61M | 0.36% | -$904.0K |
| Xencor, Inc.(XNCR) | 0 | 75,507 | +75,507 | $0 | $1.52M | 0.34% | +$1.52M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 40,000 | 40,000 | 0 | $1.09M | $1.32M | 0.30% | +$228.4K |
| Kodiak Sciences Inc.(KOD) | 1,062,062 | 500,000 | -562,062 | $2.50M | $1.30M | 0.29% | -$1.19M |
| Evogene Ltd.SHS NEW(EVGN) | 0 | 307,974 | +307,974 | $0 | $945.5K | 0.21% | +$945.5K |
| Molecular Templates Inc | 623,838 | 623,838 | 0 | $717.4K | $876.5K | 0.20% | +$159.1K |
| Applied Therapeutics Inc | 0 | 100,000 | +100,000 | $0 | $850.0K | 0.19% | +$850.0K |
| Vaxart, Inc.(VXRT) | 0 | 1,000,000 | +1,000,000 | $0 | $849.0K | 0.19% | +$849.0K |
| EyePoint, Inc.(EYPT) | 100,000 | 100,000 | 0 | $870.0K | $799.0K | 0.18% | -$71.0K |
| Ascendis Pharma A/SADR(ASND) | 0 | 5,000 | +5,000 | $0 | $746.5K | 0.17% | +$746.5K |
| Instil Bio, Inc.(TIL) | 0 | 10,517 | +10,517 | $0 | $708.0K | 0.16% | +$708.0K |
| 89bio Inc | 92,298 | 92,298 | 0 | $739.3K | $683.0K | 0.15% | -$56.3K |
| Karyopharm Therapeutics Inc.(KPTI) | 558,466 | 558,466 | 0 | $484.5K | $463.5K | 0.10% | -$21.0K |
| Black Diamond Therapeutics I | 0 | 100,000 | +100,000 | $0 | $435.0K | 0.10% | +$435.0K |
| Fractyl Health, Inc.(GUTS) | 166,666 | 166,666 | 0 | $711.7K | $421.7K | 0.10% | -$290.0K |
| Aligos Therapeutics, Inc.(ALGS) | 0 | 26,219 | +26,219 | $0 | $227.1K | 0.05% | +$227.1K |
| Yarrow Bioscience Inc(YARW) | 467,397 | 76,784 | -390,613 | $920.8K | $144.4K | 0.03% | -$776.4K |
| Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT) | 104,828 | 104,828 | 0 | $6.4K | $6.8K | 0.00% | +$398 |
| Aligos Therapeutics Inc | 655,515 | 0 | -655,515 | $229.4K | $0 | — | -$229.4K |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 172,492 | 0 | -172,492 | $7.81M | $0 | — | -$7.81M |
| Engene Holdings Inc COM | 263,841 | 0 | -263,841 | $2.49M | $0 | — | -$2.49M |
| Evogene LtdSHS | 3,079,739 | 0 | -3,079,739 | $2.00M | $0 | — | -$2.00M |
| Fulcrum Therapeutics, Inc.(FULC) | 398,436 | 0 | -398,436 | $2.47M | $0 | — | -$2.47M |
| Jasper Therapeutics, Inc.(JSPR) | 109,892 | 0 | -109,892 | $2.49M | $0 | — | -$2.49M |
| MacroGenics, Inc.(MGNX) | 370,000 | 0 | -370,000 | $1.57M | $0 | — | -$1.57M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 79,194 | 0 | -79,194 | $2.71M | $0 | — | -$2.71M |
| Morphic Hldg Inc | 486,306 | 0 | -486,306 | $16.57M | $0 | — | -$16.57M |
| Relmada Therapeutics, Inc.(RLMD) | 99,379 | 0 | -99,379 | $298.1K | $0 | — | -$298.1K |
| Soleno Therapeutics Inc | 15,000 | 0 | -15,000 | $612.0K | $0 | — | -$612.0K |
| Stoke Therapeutics, Inc.(STOK) | 141,518 | 0 | -141,518 | $1.91M | $0 | — | -$1.91M |
| Zura Bio LimitedCL A(ZURA) | 328,504 | 0 | -328,504 | $1.15M | $0 | — | -$1.15M |